Chemotherapy Acute Infusion Reactions

A Qualitative Report of the Perspectives of Patients With Cancer

David J. Bartlett, Daniel S. Childs, Carmen Radecki Breitkopf, Megan E. Grudem, Jessica L. Mitchell, Sherry A. Looker, Jennifer L. Ridgeway, Jennifer L. Lee, Joseph H. Butterfield, Saravut (John) Weroha, Aminah Jatoi

Research output: Contribution to journalArticle

Abstract

Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.

Original languageEnglish (US)
JournalAmerican Journal of Hospice and Palliative Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Drug Therapy
Fear
Neoplasms
Education
Paclitaxel
Health Personnel
Antineoplastic Agents
Nurses
Interviews

Keywords

  • carboplatin
  • education
  • infusion reactions
  • oxaliplatin
  • paclitaxel
  • qualitative

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chemotherapy Acute Infusion Reactions : A Qualitative Report of the Perspectives of Patients With Cancer. / Bartlett, David J.; Childs, Daniel S.; Radecki Breitkopf, Carmen; Grudem, Megan E.; Mitchell, Jessica L.; Looker, Sherry A.; Ridgeway, Jennifer L.; Lee, Jennifer L.; Butterfield, Joseph H.; Weroha, Saravut (John); Jatoi, Aminah.

In: American Journal of Hospice and Palliative Medicine, 01.01.2018.

Research output: Contribution to journalArticle

Bartlett, David J. ; Childs, Daniel S. ; Radecki Breitkopf, Carmen ; Grudem, Megan E. ; Mitchell, Jessica L. ; Looker, Sherry A. ; Ridgeway, Jennifer L. ; Lee, Jennifer L. ; Butterfield, Joseph H. ; Weroha, Saravut (John) ; Jatoi, Aminah. / Chemotherapy Acute Infusion Reactions : A Qualitative Report of the Perspectives of Patients With Cancer. In: American Journal of Hospice and Palliative Medicine. 2018.
@article{2b07569e2c1b4547ba205b5b15456969,
title = "Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer",
abstract = "Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.",
keywords = "carboplatin, education, infusion reactions, oxaliplatin, paclitaxel, qualitative",
author = "Bartlett, {David J.} and Childs, {Daniel S.} and {Radecki Breitkopf}, Carmen and Grudem, {Megan E.} and Mitchell, {Jessica L.} and Looker, {Sherry A.} and Ridgeway, {Jennifer L.} and Lee, {Jennifer L.} and Butterfield, {Joseph H.} and Weroha, {Saravut (John)} and Aminah Jatoi",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1049909118773995",
language = "English (US)",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Chemotherapy Acute Infusion Reactions

T2 - A Qualitative Report of the Perspectives of Patients With Cancer

AU - Bartlett, David J.

AU - Childs, Daniel S.

AU - Radecki Breitkopf, Carmen

AU - Grudem, Megan E.

AU - Mitchell, Jessica L.

AU - Looker, Sherry A.

AU - Ridgeway, Jennifer L.

AU - Lee, Jennifer L.

AU - Butterfield, Joseph H.

AU - Weroha, Saravut (John)

AU - Jatoi, Aminah

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.

AB - Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.

KW - carboplatin

KW - education

KW - infusion reactions

KW - oxaliplatin

KW - paclitaxel

KW - qualitative

UR - http://www.scopus.com/inward/record.url?scp=85046722287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046722287&partnerID=8YFLogxK

U2 - 10.1177/1049909118773995

DO - 10.1177/1049909118773995

M3 - Article

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

ER -